Skip to main content

Meritxell Genesca Ferrer

I am a senior investigator at the infectious diseases department where I lead projects focused on defining protective immune responses against pathogens in order to develop new therapies. I have mainly worked on cervicovaginal mucosa immunity, a tissue with a high impact on public health as the portal of entry for sexually transmitted infections such as HIV. The knowledge acquired during my scientific career has served to expand my research towards the understanding of immune protection against pathogens in other tissues, such as against SARS-CoV-2 in the lung.

Institutions of which they are part

Main researcher
Infectious Diseases
Vall Hebron Institut de Recerca

Meritxell Genesca Ferrer

Institutions of which they are part

Main researcher
Infectious Diseases
Vall Hebron Institut de Recerca

I am a senior investigator at the infectious diseases department where I lead projects focused on defining protective immune responses against pathogens in order to develop new therapies. I have mainly worked on cervicovaginal mucosa immunity, a tissue with a high impact on public health as the portal of entry for sexually transmitted infections such as HIV. The knowledge acquired during my scientific career has served to expand my research towards the understanding of immune protection against pathogens in other tissues, such as against SARS-CoV-2 in the lung.

Dr. Meritxell Genescà is an expert on cervical mucosal immunology and infectious diseases. She obtained the Extraordinary Award from the Autonomous University of Barcelona as a Doctor in Veterinary Medicine (2000). After obtaining her PhD in physiology (2001-2004, IIBB-CSIC), she was contracted by the University of California first as a postdoctoral researcher and then as an Associate Researcher Immunologist. For the next six years, she worked on the top animal model for HIV sexual transmission studies and specialized in mucosal immunology. In 2011, she joined the Institut d’Investigació Germans Trias i Pujol in Badalona, through a Ramón y Cajal contract, before moving to her current institution in 2017. Dr. Genescà is interested on defining the nature of protective immune responses against pathogens that use the cervicovaginal mucosa as their portal of entry, such as HIV. Her group collaborates with several basic and clinical research groups in order to conduct translational comparative medicine in the following areas: 1) HIV reservoir characterization in the cervical tissue and new strategies for its elimination; 2) Sexually Transmitted Infections and increased risk of co-infection; 3) Adjuvants and biomarkers of mucosal immunity; 4) Tissue explant models to study host-pathogen interaction and immunity (including SARS-CoV-2).
She is a member of the international Society for Mucosal Immunology (SMI), the Spanish group for AIDS study (GESIDA) and the Spanish HIV/AIDS Network (RIS). Moreover, she has participated in many dissemination activities, such as career orientation and continuous education for seniors, among others. Her track record includes over 35 articles in major international scientific journals (https://orcid.org/0000-0001-6413-3812) with an h-index of 20, numerous presentations in international meetings and several fellowships and awards. She is also actively involved in teaching and student training.

Projects

Incorporació Dr. Esteve Ribera a la RETICS en SIDA

IP: -
Collaborators: Adria Curran Fàbregas, Vicenç Falcó Ferrer, Inmaculada Ocaña Rivera, Estrella Caballero Requero, Ariadna Rando Segura, Pere Soler Palacín, María José Buzón Gómez, Paula Suanzes Diez, Jordi Navarro Mercadé, Joaquin Burgos Cibrian, Joan Rey Cano, Meritxell Genesca Ferrer, Marie Antoinette Frick, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas, Adria Curran Fàbregas
Funding agency: Instituto de Salud Carlos III
Funding: 247500
Reference: RD16/0025/0007
Duration: 01/01/2017 - 30/06/2022

Related news

Women have a mortality rate of 21% during the 30 days following surgery, compared with 11% in men, a difference that remains after taking patients’ clinical characteristics into account.

The DETECTIVE doctoral network, coordinated by the University of Turku and funded by the Marie Skłodowska-Curie Actions of the Horizon Europe programme, will train 14 predoctoral researchers in five countries.

The initiative focuses on awareness, prevention, and the normalization of sexual health check-ups among young people.

Related professionals

Eunice Blanco Vazquez

Eunice Blanco Vazquez

Administration and Management
Multidisciplinary Nursing Research Group
Read more
Neus Bellera Gotarda

Neus Bellera Gotarda

Senior researcher
Cardiovascular Diseases
Read more
Inmaculada Jimenez Ariza

Inmaculada Jimenez Ariza

Gestió i Administració
Accounting and Revenue Unit
Finance Directorate
Read more
Gemma Parramon Puig

Gemma Parramon Puig

Main researcher
Psychiatry, Mental Health and Addictions
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.